여성 생식에서 Anti-Müllerian Hormone의 역할

키워드

참고문헌 (82)

1. Visser JA, "Anti-Mullerian hormone: a new marker for ovarian function", Reproduction, 131, pp.1~9 (2006)
2. La Marca A, "Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?", Clin Endocrinol (Oxf), 64, pp.603~610 (2006)
3. Cohen-Haguenauer O, "Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome 19", Cytogenet Cell Genet, 44, pp.2~6 (1987)
4. Durlinger AL, "Regulation of ovarian function: the role of anti-Müllerian hormone", Reproduction, 124, pp.601~609 (2002)
5. Visser JA, "Anti-Müllerian hormone and folliculogenesis", Mol Cell Endocrinol, 234, pp.81~86 (2005)
6. di Clemente N, "Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone", Mol Endocrinol, 8, pp.1006~1020 (1994)
7. Baarends WM, "A novel member of the transmembrane serine", threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct, 1994, pp.120, 189~197
8. Mishina Y, "Genetic analysis of the Mullerianinhibiting substance signal transduction pathway in mammalian sexual differentiation", Genes Dev, 10, pp.2577~2587 (1996)
9. Durlinger AL, "Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary", Endocrinology, 140, pp.5789~5796 (1999)
10. Durlinger AL, "Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary", Endocrinology, 143, pp.1076~1084 (2002)
11. Durlinger AL, "Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary", Endocrinology, 142, pp.4891~4899 (2001)
12. Josso N, "The role of anti-Mullerian hormone in gonadal development", Mol Cell Endocrinol, 145, pp.3~7 (1998)
13. Burger HG, "The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample", J Clin Endocrinol Metab, 80, pp.3537~3545 (1995)
14. de Vet A, "Antimullerian hormone serum levels: a putative marker for ovarian aging", Fertil Steril, 77, pp.357~362 (2002)
15. Fanchin R, "Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3", Hum Reprod, 18, pp.323~327 (2003)
16. Sun Young Shin, "Analysis of Serum Levels of Anti-Mullerian Hormone, Inhibin B, Insulin- Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Follicle-Stimulating Hormone with Respect to Age and Menopausal Status and Follicle-Stimulating Hormone with Respect to Age and Menopausal Status", Journal of Korean Medical Science, 23(1), pp.104~110 (2008), 대한의학회
17. van Rooij IA, "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study", Fertil Steril, 83, pp.979~987 (2005)
18. La Marca A, "Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause", J Soc Gynecol Investig, 12, pp.545~548 (2005)
19. Fanchin R, "High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status", Hum Reprod, 20, pp.923~927 (2005)
20. Hehenkamp WJ, "Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation", J Clin Endocrinol Metab, 91, pp.4057~4063 (2006)
21. La Marca A, "Serum anti-Mullerian hormone throughout the human menstrual cycle", Hum Reprod, 21, pp.3103~3107 (2006)
22. Tsepelidis S, "Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women", Hum Reprod, 22, pp.1837~1840 (2007)
23. van Disseldorp J, "Relationship of serum antimullerian hormone concentration to age at menopause", J Clin Endocrinol Metab, 93, pp.2129~2134 (2008)
24. Seifer DB, "Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles", Fertil Steril, 77, pp.468~471 (2002)
25. van Rooij IA, "Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve", Hum Reprod, 17, pp.3065~3071 (2002)
26. Muttukrishna S, "Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF", ICSI patients?, 2004, pp.111, 1248~1253
27. La Marca A, "Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology", Hum Reprod, 22, pp.766~771 (2007)
28. Tremellen KP, "Anti-mullerian hormone as a marker of ovarian reserve", Aust N Z J Obstet Gynaecol, 45, pp.20~24 (2005)
29. Gnoth C, "Relevance of anti-Mullerian hormone measurement in a routine IVF program", Hum Reprod, 23, pp.1359~1365 (2008)
30. Nardo LG, "Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization", Fertil Steril (2009)
31. Jayaprakasan K, "A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation", Fertil Steril (2009)
32. Lee JR, "Anti-Mullerian hormone as a predictor of COH outcome: comparison of two commercial immunoassay kits", Fertil Steril, 90(1), pp.S219~S220 (2008)
33. Nakhuda GS, "Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization", Fertil Steril, 85, pp.1541~1543 (2006)
34. Lee TH, "Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles", Hum Reprod, 23, pp.160~167 (2008)
35. Lee JR, "Comparison of anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation between GnRH agonist and GnRH antagonist cycles", Hum Reprod, 22(1), pp.i122~i123 (2007)
36. Hazout A, "Serum antimüllerian hormone", müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol, 2004, pp.82, 1323~1329
37. Eldar-Geva T, "Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome", Hum Reprod, 20, pp.3178~3183 (2005)
38. Nelson SM, "Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-- implications for individualization of therapy", Hum Reprod, 22, pp.2414~2421 (2007)
39. Peñarrubia J, "Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment", Hum Reprod, 20, pp.915~922 (2005)
40. Smeenk JM, "Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection", Fertil Steril, 87, pp.223~226 (2007)
41. Nelson SM, "Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception", Hum Reprod (2009)
42. Laven JS, "Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age", J Clin Endocrinol Metab, 89, pp.318~323 (2004)
43. Anderson RA, "The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer", Hum Reprod, 21, pp.2583~2592 (2006)
44. Silberstein T, "Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology", Hum Reprod, 21, pp.159~163 (2006)
45. Ebner T, "Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles", Hum Reprod, 21, pp.2022~2026 (2006)
46. Lee JR, "Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles", Fertil Steril, 89, pp.860~867 (2008)
47. Takahashi C, "Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization", Fertil Steril, 89, pp.586~591 (2008)
48. Fanchin R, "Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization", J Clin Endocrinol Metab, 92, pp.1796~1802 (2007)
49. Lee JR, "Anti-Müllerian hormone concentrations in follicular fluid of preovulatory follicle: a predictor of the quality of ensuing embryo", Human Reprod, 23(1), pp.i73~ (2008)
50. Kevenaar ME, "Anti-Müllerian hormone and anti-Müllerian hormone type Ⅱ receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women", Hum Reprod, 22, pp.1547~1554 (2007)
51. Kevenaar ME, "A polymorphism in the AMH type Ⅱ receptor gene is associated with age at menopause in interaction with parity", Hum Reprod, 22, pp.2382~2388 (2007)
52. Kevenaar ME, "A functional antimullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients", J Clin Endocrinol Metab, 93, pp.1310~1316 (2008)
53. The Rotterdam ESHRE, "ASRM-Sponsored PCOS consensus workshop group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), 2004, pp.19, 41~47
54. Hughesdon PE, "Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis"", Obstet Gynecol Surv, 37, pp.59~77 (1982)
55. Jonard S, "Ultrasound examination of polycystic ovaries: is it worth counting the follicles?", Hum Reprod, 18, pp.598~603 (2003)
56. Pigny P, "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest", J Clin Endocrinol Metab, 88, pp.5957~5962 (2003)
57. Eldar-Geva T, "Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism", Hum Reprod, 20, pp.1814~1819 (2005)
58. La Marca A, "Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics", Fertil Steril, 82, pp.970~972 (2004)
59. Pigny P, "Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome", J Clin Endocrinol Metab, 91, pp.941~945 (2006)
60. Piltonen T, "Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome", Hum Reprod, 20, pp.1820~1826 (2005)
61. Lemos NA, "Decreased anti-Mullerian hormone and altered ovarian follicular cohort in infertile patients with mild", minimal endometriosis, 2008, pp.89, 1064~1068
62. Fallat ME, "Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis", Fertil Steril, 67, pp.962~965 (1997)
63. Spandorfer SD, "Obesity and in vitro fertilization: negative influences on outcome", J Reprod Med, 49, pp.973~977 (2004)
64. Freeman EW, "Association of anti-mullerian hormone levels with obesity in late reproductive-age women", Fertil Steril, 87, pp.101~106 (2007)
65. Bath LE, "Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound", Hum Reprod, 18, pp.2368~2374 (2003)
66. Yeh J, "Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage", Biochem Biophys Res Commun, 348, pp.337~344 (2006)
67. van Beek RD, "Anti-Mullerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin's Lymphoma during Childhood", J Clin Endocrinol Metab, 92, pp.3869~3874 (2007)
68. Méduri G, "Serum anti-Müllerian hormone expression in women with premature ovarian failure", Hum Reprod, 22, pp.117~123 (2004)
69. Chang HJ, "Impact of laparoscopic cystectomy on ovarian reserve : Serial changes of serum anti-Müllerian hormone levels", Fertil Steril (2009)
70. Gustafson ML, "Mullerian inhibiting substance as a marker for ovarian sex-cord tumor", N Engl J Med, 326, pp.466~471 (1992)
71. Lane AH, "Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors", Gynecol Oncol, 73, pp.51~55 (1999)
72. Rey RA, "Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement", J Clin Endocrinol Metab, 84, pp.627~631 (1999)
73. Long WQ, "Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay", J Clin Endocrinol Metab, 85, pp.540~544 (2000)
74. Healy DL, "Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors", N Engl J Med, 329, pp.1539~1542 (1993)
75. La Marca A, "The Anti-Mullerian hormone and ovarian cancer", Hum Reprod Update, 13, pp.265~273 (2007)
76. Masiakos PT, "Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type Ⅱ receptor, bind, and are responsive to MIS", Clin Cancer Res, 5, pp.3488~3499 (1999)
77. Stephen AE, "Highly purified mullerian inhibiting substance inhibits human ovarian cancer in vivo", Clin Cancer Res, 8, pp.2640~2646 (2002)
78. Pieretti-Vanmarcke R, "Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type Ⅱ receptor-directed transgenic mouse ovarian cancers in vivo", Clin Cancer Res, 12, pp.1593~1598 (2006)
79. Pieretti-Vanmarcke R, "Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer", Proc Natl Acad Sci U S A, 103, pp.17426~17431 (2006)
80. Fréour T, "Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART)", Clin Chim Acta, 375, pp.162~164 (2007)
81. Bersinger NA, "Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid", Clin Chim Acta, 384, pp.174~175 (2007)
82. Streuli I, "Clinical uses of anti-Mullerian hormone assays: pitfalls and promises", Fertil Steril, 91, pp.226~230 (2009)

관련 논문AI추천